Skip to main content

Rosa David J.'s Form 4 filing

Intuitive Surgical Inc (ISRG) · filed Feb 8, 2024

Accession no.
0001035267-24-000025
Filed
Feb 8, 2024
Trade date
Feb 7, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $31.4M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rosa David J.CIK 0001519593Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 7, 2024Common StockMOption exerciseAcquired+22,050$59.23+$1,306,021.5176,299Direct
Feb 7, 2024Common StockSSaleDisposed−12,900$389.29F2−$5,021,841163,399Direct
Feb 7, 2024Common StockMOption exerciseAcquired+22,050$57.11+$1,259,275.5185,449Direct
Feb 7, 2024Common StockSSaleDisposed−12,840$389.30F3−$4,998,612172,609Direct
Feb 7, 2024Common StockMOption exerciseAcquired+28,125$51.02+$1,434,937.5200,734Direct
Feb 7, 2024Common StockSSaleDisposed−16,150$389.23F4−$6,286,064.5184,584Direct
Feb 7, 2024Common StockMOption exerciseAcquired+40,500$49.09+$1,988,145225,084Direct
Feb 7, 2024Common StockSSaleDisposed−23,120$389.28F5−$9,000,153.6201,964Direct
Feb 7, 2024Common StockMOption exerciseAcquired+28,125$49.34+$1,387,687.5230,089Direct
Feb 7, 2024Common StockSSaleDisposed−15,700$389.29F6−$6,111,853214,389Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 7, 2024Common StockMOption exerciseDisposed−40,500$0.00$00Direct
Feb 7, 2024Common StockMOption exerciseDisposed−28,125$0.00$00Direct
Feb 7, 2024Common StockMOption exerciseDisposed−28,125$0.00$00Direct
Feb 7, 2024Common StockMOption exerciseDisposed−22,050$0.00$00Direct
Feb 7, 2024Common StockMOption exerciseDisposed−22,050$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)